LOW D-D HS 500 CONTROL

SECTION 2: Hazards identification

WHMIS 2015 Classification of the mixture

Hazard categories

Hazard statement Not classified For exposure limits see section 8 Potential adverse physicochemical, human health and environmental effects see also Ch. 9-12) Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment

Hazard pictograms

none

Signal word

none

Hazard statements

none

Precautionary statements

none Up to 5.8% of the mixture consists of component of unknown acute toxicity (dermal, inhalation) Other labeling details: for the human health. Use the product in accordance with the Good Laboratory Practice. Wear suitable protective clothing, gloves and eye/face protection. Do not let the product enter drainage system, surface and ground-water or soil. Do not empty into drains.

Other hazards which do not result in classification

The mixture does not meet the criteria for PBT or vPvB. Warning: This product contains human source material that tested non-reactive for HIV antibody, Hepatitis B Surface Antigen and Anti-HCV at the donor stage. This product, as with all human based specimens, should be handled with proper laboratory safety procedures to minimize the risk of transmission of infectious disease. The product contains bovine material (bovine serum albumin, bovine thrombin). All donor animals were sourced from BSE-free herds. The cattle received ante- and post mortem health inspection by a veterinarian, and they were apparently free from infectious and contagious material. However, the material should be treated as potentially infectious. Bovine serum albumin (BSA) might cause allergic skin reaction and/or allergy or asthma symptoms or breathing difficulties if inhaled.

2.1 Classification of the substance or mixture

This product is not hazardous according to Regulations (EC) No 1272/2008, OSHA 29 CFR 1910.1200 and Hazardous Product Regulation HPR (WHMIS 2015). Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. according to Regulations (EC) No 1272/2008, Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and Hazardous Product Regulation HPR (WHMIS 2015): Hazard class Hazard category Hazard statement Not classified For exposure limits see section 8. Potential adverse physicochemical, human health and environmental effects (see also Ch. 9-12) Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment. 2.2 Label elements, according to Regulation (EC) No 1272/2008, according to Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and according to Hazardous Product Regulation HPR (WHMIS 2015): Hazard pictogram(s): none Signal word(s): none Hazard statement(s): none Precautionary statement(s): none Up to 5.8% of the mixture consists of component of unknown acute toxicity (dermal, inhalation) Other labeling details: for the human health. Use the product in accordance with the Good Laboratory Practice. Safety precautions: Wear suitable protective clothing, gloves and eye/face protection. Do not let the product enter drainage system, surface and ground-water or soil. Do not empty into drains. 2.3 Other hazards (which do not results in the classification) The mixture does not meet the criteria for PBT or vPvB. Warning: This product contains human source material that tested non-reactive for HIV antibody, Hepatitis B Surface Antigen and Anti-HCV at the donor stage. This product, as with all human based specimens, should be handled with proper laboratory safety procedures to minimize the risk of transmission of infectious disease. The product contains bovine material (bovine serum albumin, bovine thrombin). All donor animals were sourced from BSE-free herds. The cattle received ante- and post mortem health inspection by a veterinarian, and they were apparently free from infectious and contagious material. However, the material should be treated as potentially infectious. Bovine serum albumin (BSA) might cause allergic skin reaction and/or allergy or asthma symptoms or breathing difficulties if inhaled. SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS Composition: lyophilized powder containing organic and inorganic components, bovine material and human source material. 3.1 Hazardous components: Classification Name EINECS/ CAS n° Conc. % 29 CFR 1910.1200 (HCS) Classification ELINCS n° w/w* HPR (WHMIS 2015) 1272/2008/EC Sodium Azide 247-852-1 26628-22-8 < 0.1% Acute Toxicity – Oral, cat. 2 Acute Tox. 2, H300 Index N. (Annex VI of CLP Reg.): Aquatic Acute, cat. 1** Aquatic Acute 1, H400 (M=1) 011‐004‐00‐7 Aquatic Chronic, cat. 1** Aquatic Chronic 1, H410 (M=1) For exposure limits see Ch. 8, for hazard statements text see Ch. 16. * a range may be indicated, considering batch-to batch variation. **Environmental classification according to Reg. N. 1272/2008 (EC) and subsequent amendments. The mixture contains one substance listed in the Hazardous Substance Lists and/or evaluated for carcinogenicity by IARC, NTP, OSHA: Sodium azide. See Section 11 and 15. SECTION 4. FIRST AID MEASURES 4.1 Description of first aid measures Ingestion: If swallowed rinse mouth with plenty of water provided person is conscious. Do not induce vomiting. Get medical advice if adverse symptoms appear. Inhalation exposure: If inhaled, move person to fresh air. If breathing is difficult, oxygen should be administered. Get medical advice if adverse symptoms appear. Contact with skin